腹主动脉瘤腔内修复术后30天非计划再入院:全国再入院数据库分析
多因素回归显示年轻年龄(18-49岁)、女性、医疗保险类型(Medicare或Medicaid)以及合并症(如充血性心力衰竭、癌症、肾衰竭、糖尿病)与再入院风险显著相关。
要点
- EVAR术后30天非计划再入院率为11.6%,2012年最高为12.3%。
- 年轻患者(18-49岁)再入院风险显著高于其他年龄组(OR 1.9-2.17)。
- 充血性心力衰竭、癌症、肾衰竭和糖尿病是再入院的显著相关合并症。
核心结论
- EVAR术后30天非计划再入院率自2012年略有下降,但总体仍达11.6%,不容忽视。
- 年轻年龄和合并症(如充血性心力衰竭、癌症、肾衰竭、糖尿病)与再入院强烈相关。
研究设计与样本
- 回顾性队列研究,查询2012至2014年全国再入院数据库(NRD)中所有EVAR术后30天内再入院病例。
- 共纳入120,646例接受EVAR的患者,比较再入院与未再入院者的特征,并采用多因素logistic回归识别再入院危险因素。
主要发现
- 合并症与再入院显著相关:充血性心力衰竭(OR 2.4)、外周血管病(OR 1.1)、慢性肺病(OR 1.2)、无转移癌症(OR 1.5)、转移性癌症(OR 2.2)、肾衰竭(OR 1.8)、糖尿病(OR 1.5)。
临床怎么用
- 临床应关注EVAR术后年轻患者及合并心力衰竭、癌症、肾衰竭、糖尿病的患者,加强出院后随访。
- 针对高风险患者制定个体化出院计划,可能有助于降低非计划再入院率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aneurysm repair (EVAR) is the preferred method for addressing abdominal aortic aneurysms (AAAs), with proven reduction in perioperative morbidity and mortality. There are, however limited data examining the readmissions after EVAR that are associated with increased patient morbidity and cost. As EVAR use continues its dominance in the management of AAAs, it becomes imperative to identify and mitigate risk factors associated with unplanned hospital readmissions. METHODS: The Nationwide Readmissions Database (NRD) was queried for all 30-day readmissions after an index EVAR procedure from 2012 to 2014. Preoperative patient demographics, hospital characteristics, readmission diagnosis, and costs were compared between those who were and were not readmitted within 30 days of the index operation. Multivariable logistic regression was used to identify potential risk factors associated with unplanned readmissions within 30 days. RESULTS: We identified 120,646 patients who underwent an EVAR from 2012 to 2014 in the United States. The overall unplanned readmission rate during this period was 11.6% (n = 14,073) within 30 days of the index EVAR procedure. The readmission rate was the highest in 2012, with a rate of 12.3% (P = .02). Multivariate regression analysis showed that EVAR readmissions were significantly higher in patients who were of younger age (18 to 49 years) compared with other age groups (odds ratio [OR], 1.9-2.17; P < .001), female sex (OR, 1.367; P < .001), had Medicare (OR, 1.39) or Medicaid (OR, 1.25) insurance, or a combination of these. Underlying patient comorbidities significantly associated with readmissions included congestive heart failure (OR, 2.4), peripheral vascular disease (OR, 1.1), chronic pulmonary disease (OR, 1.2), cancer with no metastasis (OR, 1.5), metastatic cancer (OR, 2.2), renal failure (OR, 1.8), and diabetes (OR, 1.5). CONCLUSIONS: The trend in 30-day readmission rates after EVAR has decreased slightly since 2012, but overall rates are at 11.6%, which is not insubstantial. Patient factors strongly associated with hospital readmission were younger age and patient comorbidities, including congestive heart failure, concurrent cancer diagnosis, renal failure, and diabetes.
引用
- Dua A, Rothenberg KA, Wohlaer M, et al. Unplanned 30-day readmissions after endovascular aneurysm repair: An analysis using the Nationwide Readmissions Database. J Vasc Surg. 2019. PMID: 31147138. doi:10.1016/j.jvs.2019.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。